aluates Reports

$ 0.0

Automative

Global Olanzapine Orally Disintegrating Tablets (ODT) Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-38U15343

Global Olanzapine Orally Disintegrating Tablets ODT Market Research Report 2023

BUY CHAPTERS

Global Olanzapine Orally Disintegrating Tablets (ODT) Market Research Report 2025

Code: QYRE-Auto-38U15343

Report

January 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly and Company

Teva Pharmaceutical

Dr. Reddy’s Laboratories

Apotex

Mylan Pharmaceuticals

Sandoz Canada

Macleods Pharma

Aurobindo Pharma

Jubilant Lifesciences

Abbott

Olanzapine Orally Disintegrating Tablets (ODT) Market Size

The global market for Olanzapine Orally Disintegrating Tablets (ODT) was valued at US$ 70.5 million in the year 2024 and is projected to reach a revised size of US$ 117 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Olanzapine Orally Disintegrating Tablets (ODT) Market

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Olanzapine Orally Disintegrating Tablets (ODT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olanzapine Orally Disintegrating Tablets (ODT).

The Olanzapine Orally Disintegrating Tablets (ODT) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Olanzapine Orally Disintegrating Tablets (ODT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Olanzapine Orally Disintegrating Tablets (ODT) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Olanzapine Orally Disintegrating Tablets (ODT) Market Report

Report Metric	Details
Report Name	Olanzapine Orally Disintegrating Tablets (ODT) Market
Accounted market size in year	US$ 70.5 million
Forecasted market size in 2031	US$ 117 million
CAGR	7.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Original Drug Generic Drug
Segment by Application	Hospital Clinic Retail Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Eli Lilly and Company, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc., Mylan Pharmaceuticals, Sandoz Canada, Macleods Pharma, Aurobindo Pharma, Jubilant Lifesciences, Abbott
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Olanzapine Orally Disintegrating Tablets (ODT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Olanzapine Orally Disintegrating Tablets (ODT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Olanzapine Orally Disintegrating Tablets (ODT) Market growing?

Ans: The Olanzapine Orally Disintegrating Tablets (ODT) Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Olanzapine Orally Disintegrating Tablets (ODT) Market size in 2031?

Ans: The Olanzapine Orally Disintegrating Tablets (ODT) Market size in 2031 will be US$ 117 million.

Who are the main players in the Olanzapine Orally Disintegrating Tablets (ODT) Market report?

Ans: The main players in the Olanzapine Orally Disintegrating Tablets (ODT) Market are Eli Lilly and Company, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc., Mylan Pharmaceuticals, Sandoz Canada, Macleods Pharma, Aurobindo Pharma, Jubilant Lifesciences, Abbott

What are the Application segmentation covered in the Olanzapine Orally Disintegrating Tablets (ODT) Market report?

Ans: The Applications covered in the Olanzapine Orally Disintegrating Tablets (ODT) Market report are Hospital, Clinic, Retail Pharmacy, Other

What are the Type segmentation covered in the Olanzapine Orally Disintegrating Tablets (ODT) Market report?

Ans: The Types covered in the Olanzapine Orally Disintegrating Tablets (ODT) Market report are Original Drug, Generic Drug

Recommended Reports

Orally Disintegrating Tablets

Mental Disorder Drugs

Drug Delivery Formats

1 Olanzapine Orally Disintegrating Tablets (ODT) Market Overview

1.1 Product Definition

1.2 Olanzapine Orally Disintegrating Tablets (ODT) by Type

1.2.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Original Drug

1.2.3 Generic Drug

1.3 Olanzapine Orally Disintegrating Tablets (ODT) by Application

1.3.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Retail Pharmacy

1.3.5 Other

1.4 Global Olanzapine Orally Disintegrating Tablets (ODT) Market Size Estimates and Forecasts

1.4.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue 2020-2031

1.4.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales 2020-2031

1.4.3 Global Olanzapine Orally Disintegrating Tablets (ODT) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Olanzapine Orally Disintegrating Tablets (ODT) Market Competition by Manufacturers

2.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Olanzapine Orally Disintegrating Tablets (ODT) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Olanzapine Orally Disintegrating Tablets (ODT), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Olanzapine Orally Disintegrating Tablets (ODT), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Olanzapine Orally Disintegrating Tablets (ODT), Product Type & Application

2.7 Global Key Manufacturers of Olanzapine Orally Disintegrating Tablets (ODT), Date of Enter into This Industry

2.8 Global Olanzapine Orally Disintegrating Tablets (ODT) Market Competitive Situation and Trends

2.8.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Olanzapine Orally Disintegrating Tablets (ODT) Players Market Share by Revenue

2.8.3 Global Olanzapine Orally Disintegrating Tablets (ODT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Olanzapine Orally Disintegrating Tablets (ODT) Market Scenario by Region

3.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Region: 2020-2031

3.2.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Region: 2020-2025

3.2.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Region: 2026-2031

3.3 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Region: 2020-2031

3.3.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Region: 2020-2025

3.3.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Region: 2026-2031

3.4 North America Olanzapine Orally Disintegrating Tablets (ODT) Market Facts & Figures by Country

3.4.1 North America Olanzapine Orally Disintegrating Tablets (ODT) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2020-2031)

3.4.3 North America Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Olanzapine Orally Disintegrating Tablets (ODT) Market Facts & Figures by Country

3.5.1 Europe Olanzapine Orally Disintegrating Tablets (ODT) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2020-2031)

3.5.3 Europe Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Market Facts & Figures by Region

3.6.1 Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Sales by Region (2020-2031)

3.6.3 Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Olanzapine Orally Disintegrating Tablets (ODT) Market Facts & Figures by Country

3.7.1 Latin America Olanzapine Orally Disintegrating Tablets (ODT) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2020-2031)

3.7.3 Latin America Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Market Facts & Figures by Country

3.8.1 Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Type (2020-2031)

4.1.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Type (2020-2025)

4.1.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Type (2026-2031)

4.1.3 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Type (2020-2031)

4.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Type (2020-2031)

4.2.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Type (2020-2025)

4.2.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Type (2026-2031)

4.2.3 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Type (2020-2031)

4.3 Global Olanzapine Orally Disintegrating Tablets (ODT) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Application (2020-2031)

5.1.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Application (2020-2025)

5.1.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Application (2026-2031)

5.1.3 Global Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Application (2020-2031)

5.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Application (2020-2031)

5.2.1 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Application (2020-2025)

5.2.2 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Application (2026-2031)

5.2.3 Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Application (2020-2031)

5.3 Global Olanzapine Orally Disintegrating Tablets (ODT) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Eli Lilly and Company

6.1.1 Eli Lilly and Company Company Information

6.1.2 Eli Lilly and Company Description and Business Overview

6.1.3 Eli Lilly and Company Olanzapine Orally Disintegrating Tablets (ODT) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Eli Lilly and Company Olanzapine Orally Disintegrating Tablets (ODT) Product Portfolio

6.1.5 Eli Lilly and Company Recent Developments/Updates

6.2 Teva Pharmaceutical

6.2.1 Teva Pharmaceutical Company Information

6.2.2 Teva Pharmaceutical Description and Business Overview

6.2.3 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets (ODT) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets (ODT) Product Portfolio

6.2.5 Teva Pharmaceutical Recent Developments/Updates

6.3 Dr. Reddy's Laboratories

6.3.1 Dr. Reddy's Laboratories Company Information

6.3.2 Dr. Reddy's Laboratories Description and Business Overview

6.3.3 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets (ODT) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets (ODT) Product Portfolio

6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates

6.4 Apotex Inc.

6.4.1 Apotex Inc. Company Information

6.4.2 Apotex Inc. Description and Business Overview

6.4.3 Apotex Inc. Olanzapine Orally Disintegrating Tablets (ODT) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Apotex Inc. Olanzapine Orally Disintegrating Tablets (ODT) Product Portfolio

6.4.5 Apotex Inc. Recent Developments/Updates

6.5 Mylan Pharmaceuticals

6.5.1 Mylan Pharmaceuticals Company Information

6.5.2 Mylan Pharmaceuticals Description and Business Overview

6.5.3 Mylan Pharmaceuticals Olanzapine Orally Disintegrating Tablets (ODT) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Mylan Pharmaceuticals Olanzapine Orally Disintegrating Tablets (ODT) Product Portfolio

6.5.5 Mylan Pharmaceuticals Recent Developments/Updates

6.6 Sandoz Canada

6.6.1 Sandoz Canada Company Information

6.6.2 Sandoz Canada Description and Business Overview

6.6.3 Sandoz Canada Olanzapine Orally Disintegrating Tablets (ODT) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Sandoz Canada Olanzapine Orally Disintegrating Tablets (ODT) Product Portfolio

6.6.5 Sandoz Canada Recent Developments/Updates

6.7 Macleods Pharma

6.7.1 Macleods Pharma Company Information

6.7.2 Macleods Pharma Description and Business Overview

6.7.3 Macleods Pharma Olanzapine Orally Disintegrating Tablets (ODT) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Macleods Pharma Olanzapine Orally Disintegrating Tablets (ODT) Product Portfolio

6.7.5 Macleods Pharma Recent Developments/Updates

6.8 Aurobindo Pharma

6.8.1 Aurobindo Pharma Company Information

6.8.2 Aurobindo Pharma Description and Business Overview

6.8.3 Aurobindo Pharma Olanzapine Orally Disintegrating Tablets (ODT) Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Aurobindo Pharma Olanzapine Orally Disintegrating Tablets (ODT) Product Portfolio

6.8.5 Aurobindo Pharma Recent Developments/Updates

6.9 Jubilant Lifesciences

6.9.1 Jubilant Lifesciences Company Information

6.9.2 Jubilant Lifesciences Description and Business Overview

6.9.3 Jubilant Lifesciences Olanzapine Orally Disintegrating Tablets (ODT) Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Jubilant Lifesciences Olanzapine Orally Disintegrating Tablets (ODT) Product Portfolio

6.9.5 Jubilant Lifesciences Recent Developments/Updates

6.10 Abbott

6.10.1 Abbott Company Information

6.10.2 Abbott Description and Business Overview

6.10.3 Abbott Olanzapine Orally Disintegrating Tablets (ODT) Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Abbott Olanzapine Orally Disintegrating Tablets (ODT) Product Portfolio

6.10.5 Abbott Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Olanzapine Orally Disintegrating Tablets (ODT) Industry Chain Analysis

7.2 Olanzapine Orally Disintegrating Tablets (ODT) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Olanzapine Orally Disintegrating Tablets (ODT) Production Mode & Process Analysis

7.4 Olanzapine Orally Disintegrating Tablets (ODT) Sales and Marketing

7.4.1 Olanzapine Orally Disintegrating Tablets (ODT) Sales Channels

7.4.2 Olanzapine Orally Disintegrating Tablets (ODT) Distributors

7.5 Olanzapine Orally Disintegrating Tablets (ODT) Customer Analysis

8 Olanzapine Orally Disintegrating Tablets (ODT) Market Dynamics

8.1 Olanzapine Orally Disintegrating Tablets (ODT) Industry Trends

8.2 Olanzapine Orally Disintegrating Tablets (ODT) Market Drivers

8.3 Olanzapine Orally Disintegrating Tablets (ODT) Market Challenges

8.4 Olanzapine Orally Disintegrating Tablets (ODT) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Eli Lilly and Company

Teva Pharmaceutical

Dr. Reddy’s Laboratories

Apotex

Mylan Pharmaceuticals

Sandoz Canada

Macleods Pharma

Aurobindo Pharma

Jubilant Lifesciences

Abbott

List of Tables

Table 1. Global Olanzapine Orally Disintegrating Tablets (ODT) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Olanzapine Orally Disintegrating Tablets (ODT) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Olanzapine Orally Disintegrating Tablets (ODT) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Olanzapine Orally Disintegrating Tablets (ODT) Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Olanzapine Orally Disintegrating Tablets (ODT), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Olanzapine Orally Disintegrating Tablets (ODT), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Olanzapine Orally Disintegrating Tablets (ODT), Product Type & Application

Table 12. Global Key Manufacturers of Olanzapine Orally Disintegrating Tablets (ODT), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Olanzapine Orally Disintegrating Tablets (ODT) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olanzapine Orally Disintegrating Tablets (ODT) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Olanzapine Orally Disintegrating Tablets (ODT) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Region (2020-2025) & (K Units)

Table 18. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Region (2020-2025)

Table 19. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales by Region (2026-2031) & (K Units)

Table 20. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Region (2026-2031)

Table 21. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Region (2020-2025)

Table 23. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Region (2026-2031)

Table 25. North America Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2020-2025) & (K Units)

Table 27. North America Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2026-2031) & (K Units)

Table 28. North America Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2020-2025) & (K Units)

Table 32. Europe Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2026-2031) & (K Units)

Table 33. Europe Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units) by Type (2020-2025)

Table 51. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units) by Type (2026-2031)

Table 52. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Type (2020-2025)

Table 53. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Type (2026-2031)

Table 54. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Type (2020-2025)

Table 57. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Type (2026-2031)

Table 58. Global Olanzapine Orally Disintegrating Tablets (ODT) Price (US$/Unit) by Type (2020-2025)

Table 59. Global Olanzapine Orally Disintegrating Tablets (ODT) Price (US$/Unit) by Type (2026-2031)

Table 60. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units) by Application (2020-2025)

Table 61. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units) by Application (2026-2031)

Table 62. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Application (2020-2025)

Table 63. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Application (2026-2031)

Table 64. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Application (2020-2025)

Table 67. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Application (2026-2031)

Table 68. Global Olanzapine Orally Disintegrating Tablets (ODT) Price (US$/Unit) by Application (2020-2025)

Table 69. Global Olanzapine Orally Disintegrating Tablets (ODT) Price (US$/Unit) by Application (2026-2031)

Table 70. Eli Lilly and Company Company Information

Table 71. Eli Lilly and Company Description and Business Overview

Table 72. Eli Lilly and Company Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Eli Lilly and Company Olanzapine Orally Disintegrating Tablets (ODT) Product

Table 74. Eli Lilly and Company Recent Developments/Updates

Table 75. Teva Pharmaceutical Company Information

Table 76. Teva Pharmaceutical Description and Business Overview

Table 77. Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets (ODT) Product

Table 79. Teva Pharmaceutical Recent Developments/Updates

Table 80. Dr. Reddy's Laboratories Company Information

Table 81. Dr. Reddy's Laboratories Description and Business Overview

Table 82. Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets (ODT) Product

Table 84. Dr. Reddy's Laboratories Recent Developments/Updates

Table 85. Apotex Inc. Company Information

Table 86. Apotex Inc. Description and Business Overview

Table 87. Apotex Inc. Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Apotex Inc. Olanzapine Orally Disintegrating Tablets (ODT) Product

Table 89. Apotex Inc. Recent Developments/Updates

Table 90. Mylan Pharmaceuticals Company Information

Table 91. Mylan Pharmaceuticals Description and Business Overview

Table 92. Mylan Pharmaceuticals Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Mylan Pharmaceuticals Olanzapine Orally Disintegrating Tablets (ODT) Product

Table 94. Mylan Pharmaceuticals Recent Developments/Updates

Table 95. Sandoz Canada Company Information

Table 96. Sandoz Canada Description and Business Overview

Table 97. Sandoz Canada Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Sandoz Canada Olanzapine Orally Disintegrating Tablets (ODT) Product

Table 99. Sandoz Canada Recent Developments/Updates

Table 100. Macleods Pharma Company Information

Table 101. Macleods Pharma Description and Business Overview

Table 102. Macleods Pharma Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Macleods Pharma Olanzapine Orally Disintegrating Tablets (ODT) Product

Table 104. Macleods Pharma Recent Developments/Updates

Table 105. Aurobindo Pharma Company Information

Table 106. Aurobindo Pharma Description and Business Overview

Table 107. Aurobindo Pharma Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Aurobindo Pharma Olanzapine Orally Disintegrating Tablets (ODT) Product

Table 109. Aurobindo Pharma Recent Developments/Updates

Table 110. Jubilant Lifesciences Company Information

Table 111. Jubilant Lifesciences Description and Business Overview

Table 112. Jubilant Lifesciences Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Jubilant Lifesciences Olanzapine Orally Disintegrating Tablets (ODT) Product

Table 114. Jubilant Lifesciences Recent Developments/Updates

Table 115. Abbott Company Information

Table 116. Abbott Description and Business Overview

Table 117. Abbott Olanzapine Orally Disintegrating Tablets (ODT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Abbott Olanzapine Orally Disintegrating Tablets (ODT) Product

Table 119. Abbott Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Olanzapine Orally Disintegrating Tablets (ODT) Distributors List

Table 123. Olanzapine Orally Disintegrating Tablets (ODT) Customers List

Table 124. Olanzapine Orally Disintegrating Tablets (ODT) Market Trends

Table 125. Olanzapine Orally Disintegrating Tablets (ODT) Market Drivers

Table 126. Olanzapine Orally Disintegrating Tablets (ODT) Market Challenges

Table 127. Olanzapine Orally Disintegrating Tablets (ODT) Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Olanzapine Orally Disintegrating Tablets (ODT)

Figure 2. Global Olanzapine Orally Disintegrating Tablets (ODT) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Olanzapine Orally Disintegrating Tablets (ODT) Market Share by Type: 2024 & 2031

Figure 4. Original Drug Product Picture

Figure 5. Generic Drug Product Picture

Figure 6. Global Olanzapine Orally Disintegrating Tablets (ODT) Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Olanzapine Orally Disintegrating Tablets (ODT) Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Retail Pharmacy

Figure 11. Other

Figure 12. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Olanzapine Orally Disintegrating Tablets (ODT) Market Size (2020-2031) & (US$ Million)

Figure 14. Global Olanzapine Orally Disintegrating Tablets (ODT) Sales (2020-2031) & (K Units)

Figure 15. Global Olanzapine Orally Disintegrating Tablets (ODT) Average Price (US$/Unit) & (2020-2031)

Figure 16. Olanzapine Orally Disintegrating Tablets (ODT) Report Years Considered

Figure 17. Olanzapine Orally Disintegrating Tablets (ODT) Sales Share by Manufacturers in 2024

Figure 18. Global Olanzapine Orally Disintegrating Tablets (ODT) Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Olanzapine Orally Disintegrating Tablets (ODT) Players: Market Share by Revenue in Olanzapine Orally Disintegrating Tablets (ODT) in 2024

Figure 20. Olanzapine Orally Disintegrating Tablets (ODT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Olanzapine Orally Disintegrating Tablets (ODT) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Country (2020-2031)

Figure 23. North America Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Country (2020-2031)

Figure 24. United States Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Country (2020-2031)

Figure 27. Europe Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Country (2020-2031)

Figure 28. Germany Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Region (2020-2031)

Figure 35. China Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Country (2020-2031)

Figure 43. Latin America Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Olanzapine Orally Disintegrating Tablets (ODT) Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Olanzapine Orally Disintegrating Tablets (ODT) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Olanzapine Orally Disintegrating Tablets (ODT) by Type (2020-2031)

Figure 53. Global Revenue Market Share of Olanzapine Orally Disintegrating Tablets (ODT) by Type (2020-2031)

Figure 54. Global Olanzapine Orally Disintegrating Tablets (ODT) Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Olanzapine Orally Disintegrating Tablets (ODT) by Application (2020-2031)

Figure 56. Global Revenue Market Share of Olanzapine Orally Disintegrating Tablets (ODT) by Application (2020-2031)

Figure 57. Global Olanzapine Orally Disintegrating Tablets (ODT) Price (US$/Unit) by Application (2020-2031)

Figure 58. Olanzapine Orally Disintegrating Tablets (ODT) Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global VDRL Rotator Market Research Report 2025

Global Blood Test Software Market Research Report 2025

Targeted Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood Chemistry Analysis Software Market Research Report 2025

Global Macromolecular CDMO Market Research Report 2025

Global Nasal Antiseptics Market Research Report 2025

Global Blood Functional Analysis Software Market Research Report 2025

Vegetarian Cellulose Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adhesive Dressings Market Research Report 2025

Global Haemodialysis Concentrates Market Research Report 2024

Sterile Intravenous Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sterile Silicone Dressing Market Research Report 2025

Cholesterol Management Supplement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Coagulation Monitoring Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Aripiprazole Orally Disintegrating Tablets ODT Market Research Report 2025

Synthetic Bone Wax Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Herbal Botanical Extract Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tigecycline for Injection Market Research Report 2025

Oral Hydrogel Wound Dressing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions